Treatment of Staphylococcus aureus Tracheitis

Initial Assessment and Management

• Obtain cultures from tracheal secretions before starting antibiotics to confirm S. aureus and determine antimicrobial susceptibility 1

Empiric Antibiotic Therapy

• The Infectious Diseases Society of America recommends vancomycin or linezolid for empiric MRSA coverage in patients with Staphylococcus aureus tracheitis 1, 2
• Vancomycin is a first-line option for MRSA coverage, with a recommended dose of 600 mg IV twice daily 1, 2
• Linezolid 600 mg IV twice daily is an alternative option for MRSA coverage 1, 2
• Clindamycin 600 mg three times daily is an option for oral therapy if local resistance rates are <10% 4, 5

Treatment Duration

• The Infectious Diseases Society of America recommends 7-14 days of therapy for S. aureus respiratory infections, individualized based on clinical response 4, 5

Pediatric Considerations

• Vancomycin is recommended for empiric MRSA coverage in hospitalized children 4, 7
• Clindamycin 10–13 mg/kg/dose IV every 6–8 hours is an option for empirical therapy in children if local clindamycin resistance is low (<10%) 4, 7
• Linezolid dosing is 600 mg PO/IV twice daily for children >12 years of age and 10 mg/kg/dose PO/IV every 8 hours for children <12 years of age 4, 7
• Tetracyclines should not be used in children <8 years of age 4, 7

Monitoring and Follow-up

• Assess clinical response within 48-72 hours of initiating therapy 1
• Adjust antibiotics based on culture and susceptibility results 1, 2

Prevention of Recurrence

• Good personal hygiene with regular handwashing is recommended to prevent recurrence 3
• Environmental hygiene measures focusing on high-touch surfaces are recommended to prevent recurrence 3
• Consider decolonization for patients with recurrent S. aureus infections 3

Common Pitfalls to Avoid

• Failure to obtain appropriate cultures before initiating antibiotics can lead to inadequate treatment 1
• Continuing broad-spectrum coverage when targeted therapy based on susceptibilities is available can lead to unnecessary antibiotic use 1, 2
• Using tetracyclines in children under 8 years of age is not recommended 4, 7